A vulnerability was found in B. Braun OnlineSuite 3.0. It has been rated as very critical. Affected by this issue is an unknown functionality. The manipulation with an unknown input leads to a expression language injection vulnerability. Using CWE to declare the problem leads to CWE-917. The product constructs all or part of an expression language (EL) statement in a framework such as a Java Server Page (JSP) using externally-influenced input from an upstream component, but it does not neutralize or incorrectly neutralizes special elements that could modify the intended EL statement before it is executed. Impacted is confidentiality, integrity, and availability. CVE summarizes:

An improper neutralization of inputs used in expression language allows remote code execution with the highest privileges on the server.

The advisory is available at bbraun.com. This vulnerability is handled as CVE-2025-3322 since 04/05/2025. The exploitation is known to be easy. The attack may be launched remotely. No form of authentication is required for exploitation. The technical details are unknown and an exploit is not available. The structure of the vulnerability defines a possible price range of USD $0-$5k at the moment (estimation calculated on 06/06/2025).

There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.

The vulnerability is also documented in the vulnerability database at EUVD (EUVD-2025-17092). If you want to get best quality of vulnerability data, you may have to visit VulDB.

Productinfo

Vendor

• B. Braun

Name

• OnlineSuite

Version

• 3.0

CPE 2.3info

• 🔒

CPE 2.2info

• 🔒

CVSSv4info

CVSSv3info

CVSSv2info

Exploitinginfo

Threat Intelligenceinfo

Countermeasuresinfo

Timelineinfo

Sourcesinfo

Entryinfo

Discussion